In May of this year, Aventis Pharmaceutical, a subsidiary of the pharmaceutical company Sanofi-Aventis, resolved charges that it intentionally misreported drug prices for anti-inflammatory nasal sprays, thereby lowering its rebate payments to Medicaid. In its settlement with the Justice Department, the company committed to pay a $95.5 million fine.Ver anteriores...



No hay comentarios:
Publicar un comentario